In summary, these findings indicate that reduced AMPK activity in adipose tissue might be an important pathogenic factor in obesity and the related metabolic syndrome, and the chronic activation of AMPK by A-769662 protects from HFD-induced adiposity and metabolic dysfunction. This evidence concerns the gene PRKAA1 and Obesity.